advertisement
European Journal of Ophthalmology 14
Showing records 1 to 14 | Display all abstracts in European Journal of Ophthalmology18526 Apoptosis and anti-apoptosis signalling in glaucomatous retinopathy
Tatton WG; Chalmers-Redman RME; Tatton NA
European Journal of Ophthalmology 2001; 11: Suppl 2 S12-S22
18495 Measuring structural changes in the optic nerve head and retinal nerve fibre layer
Anton A
European Journal of Ophthalmology 2001; 11: Suppl 2 S50-S56
18462 Evaluation of glaucomatous visual field loss with locally condensed grids using fundus-oriented perimetry (FOP)
Schiefer U; Malsam A; Flad M; Stumpp F; Dietrich TJ; Paetzold J; Vonthein R; Knorr M; Denk PO
European Journal of Ophthalmology 2001; 11: Suppl 2 S57-S62
18460 Electrophysiological approaches for early detection of glaucoma
Bach M
European Journal of Ophthalmology 2001; 11: Suppl 2 S41-S49
18409 Changes in visual acuity and refraction in the exfoliation syndrome: a five-year follow-up study
Puska PM; Tarkkanen AHA
European Journal of Ophthalmology 2001; 11: 245-251
18380 Brimonidine (Alphagan™): a clinical profile four years after launch
David R
European Journal of Ophthalmology 2001; 11: Suppl 2 S72-S77
18378 Influence of topical brimonidine on visual field in glaucoma
Ruiz Lapuente C; Ruiz Lapuente A; Link B
European Journal of Ophthalmology 2001; 11 Suppl: 2 S67-S71
18376 Brimonidine's neuroprotective effects against transient ischaemia-induced retinal ganglion cell death
Vidal-Sanz M; Lafuente MP; Mayor-Torroglosa S; Aguilera ME; Miralles de Imperial J; Villegas-Perez MP
European Journal of Ophthalmology 2001; 11: Suppl 2 S36-S40
18375 Alpha-2 adrenergic receptor agonists are neuroprotective in experimental models of glaucoma
Wheeler LA; Woldemussie E
European Journal of Ophthalmology 2001; 11: Suppl 2 S30-S35
18370 Beta-adrenergic antagonists in the treatment of glaucoma
Gandolfi ; Cimino L
European Journal of Ophthalmology 2001; 11: Suppl 2 S63-S66
18369 Color Doppler imaging study in patients with primary open-angle glaucoma treated with timolol 0.5% and carteolol 2%
Montanari P; Marangoni P; Oldani A; Ratiglia R; Raiteri M; Berardinelli L
European Journal of Ophthalmology 2001; 11: 240-244
18338 Animal and culture models of glaucoma for studying neuroprotection
Levin LA
European Journal of Ophthalmology 2001; 11: Suppl 2 S23-S29
18337 Neuroprotection as a treatment for glaucoma: pharmacological and immunological approaches
Schwartz M
European Journal of Ophthalmology 2001; 11: Suppl 2 S7-S11
18285 Trabeculectomy with and without mitomycin-C in a black African population
Mwanza JCK; Kabasele PM
European Journal of Ophthalmology 2001; 11: 261-263
